Physician profile
Gary A Tuma
NPI 1083707541
$11,363.05
in general payments reported to CMS, 2019-2025
19 companies · $1,134 in 2025
The $1,134 reported for 2025 was more than what 75% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $39.99 · 2021: $589 · 2022: $266 · 2023: $7,400 · 2024: $1,727 · 2025: $1,134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,042 · Food and Beverage: $2,115 · Education: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,042.00 |
| Food and Beverage | $2,114.58 |
| Education | $104.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $8,968.74 | 2021-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Abbvie INC. | $597.58 | 2023-2025 | Alloderm |
| Allergan, INC. | $303.96 | 2019-2022 | |
| Motiva USA, LLC | $186.82 | 2025 | |
| Onkos Surgical, INC. | $183.17 | 2021 | |
| Medtronic, INC. | $178.58 | 2025 | Signia |
| Edwards Lifesciences Corporation | $174.89 | 2025 | Sapien 3 Ultra Resilia |
| Telix Pharmaceuticals | $151.33 | 2025 | Illuccix |
| Acera Surgical, INC. | $109.16 | 2024-2025 | Restrata Wound Matrix |
| Davol INC. | $104.00 | 2025 | |
| Ethicon US, LLC | $99.98 | 2020-2024 | Ethicon |
| Integra Lifesciences Corporation | $96.08 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Dilon Technologies, INC. | $51.73 | 2024 | Hemoblast Bellows |
| Musculoskeletal Transplant Foundation INC. | $36.99 | 2024-2025 | |
| Urgo Medical North America, LLC | $36.67 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $30.74 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Kci USA, INC. | $19.65 | 2023 | V.A.C. Veraflo, Prevena Restor Bellaform |
| Merck Sharp & Dohme LLC | $17.00 | 2023 | Lynparza, Keytruda |
| Pacira Pharmaceuticals Incorporated | $15.98 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Tuma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.